Everolimus in Patients with Autosomal Dominant Polycystic Kidney DiseaseGerd Walz, Kai‐Uwe Eckardt, Christoph Wanner et al.|New England Journal of Medicine|2010Cited by 574
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpuraLinus A. Völker, H Felten, Jessica Kaufeld et al.|Journal of Thrombosis and Haemostasis|2023Cited by 50